IRTC IRhythm Technologies Inc.

iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

SAN FRANCISCO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2023 after the close of trading on Thursday, February 22, 2024. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at .

About iRhythm Technologies, Inc.

iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact

Stephanie Zhadkevich

(919) 452-5430

Media Contact

Saige Smith

(262) 289-7065



EN
08/02/2024

Underlying

IRTCIRhythm Technologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IRhythm Technologies Inc.

 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies Announces First Quarter 2024 Financial Results

iRhythm Technologies Announces First Quarter 2024 Financial Results SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended March 31, 2024. First Quarter 2024 Financial Highlights Revenue of $131.9 million, a 18.4% increase compared to first quarter 2023Gross margin of 66.3%, a 160-basis point decline compared to first quarter 2023Unrestricted cash, cash equivalents and marketable securitie...

May 2, 2024 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Technologies to Report First Quarter 2024 Financial Results on...

iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024 SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 after the close of trading on Thursday, May 2, 2024. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the presentation...

April 18, 2024 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Seni...

iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the closing of its offering of 1.50% Convertible Senior Notes due 2029 (the “notes”) for gross proceeds of $661.25 million in a private placement to persons reasona...

March 8, 2024 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible...

iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029 SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the pricing of its offering of $575.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Secu...

March 5, 2024 1 EN
 PRESS RELEASE
Free
IRTC IRhythm Technol...

iRhythm Announces Proposed Offering of $450.0 Million of Convertible S...

iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and help prevent disease, announced today that it intends to offer, subject to market conditions and other factors, $450.0 million aggregate principal amount of Convertible Senior Notes due 2029 (the “notes”) in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to...

March 4, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch